Long-term follow-up of patients after transcatheter direct current ablation of the atrioventricular junction

Department of Medicine, University of California, San Francisco.

The long-term follow-up study (41 +/- 23 months) of 47 patients undergoing direct current ablation because of drug-resistant supraventricular arrhythmias is reported. Significant early complications occurred in four patients and included hypotension, pericarditis, nonsustained polymorphic ventricular tachycardia and one sudden death. In 42 patients (86%), complete atrioventricular (AV) block was initially achieved. During the follow-up period, AV conduction resumed in 2 of these 42 patients. Of the seven patients in whom ablation was unsuccessful, two developed late complete AV block and three had symptomatic improvement. An improved activity level was reported among 83% of the patients with successful ablation. Health care utilization manifest as the number of hospital admissions per year before and after ablation decreased significantly after ablation (2.4 +/- 2.0 versus 0.3 +/- 0.5, p less than 0.001). Echocardiographic evaluation in five patients with a depressed left ventricular ejection fraction (27 +/- 7%) before ablation showed a significant increase (45 +/- 14%, p less than 0.05) after an average follow-up period of 31 months. New onset of congestive heart failure occurred after ablation in four patients, of whom two had no structural heart disease. The total mortality rate, including the one patient with sudden death, was 17% and was significantly higher among patients with underlying structural heart disease. Transcatheter direct current ablation is an effective treatment in patients with drug-resistant supraventricular tachycardia, providing a beneficial long-term outcome including an improved quality of life and a decrease in health care utilization.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				M. Brignole, M. Gammage, E. Puggioni, P. Alboni, A. Raviele, R. Sutton, P. Vardas, M.G. Bongiorni, L. Bergfeldt, C. Menozzi, et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation Eur. Heart J., April 1, 2005; 26(7): 712 - 722. [Abstract] [Full Text] [PDF]

				P. Nerheim, S. Birger-Botkin, L. Piracha, and B. Olshansky Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia Circulation, July 20, 2004; 110(3): 247 - 252. [Abstract] [Full Text] [PDF]

				M. D.M Engelmann and S. Pehrson Quality of life in nonpharmacologic treatment of atrial fibrillation Eur. Heart J., August 1, 2003; 24(15): 1387 - 1400. [Abstract] [Full Text] [PDF]

				M. Brignole A novel use of cardiac pacing to improve cardiac function, quality of life and (hopefully) survival in patients with heart failure and permanent atrial fibrillation Eur. Heart J., November 2, 2002; 23(22): 1732 - 1736. [Full Text] [PDF]

				C. J. Howes, M. C. Reid, C. Brandt, B. Ruo, M. W. Yerkey, B. Prasad, C. Lin, P. Peduzzi, and M. D. Ezekowitz Exercise Tolerance and Quality of Life in Elderly Patients with Chronic Atrial Fibrillation Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 23 - 29. [Abstract] [PDF]

				T Levy, S Walker, M Mason, P Spurrell, S Rex, S Brant, and V Paul Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study Heart, February 1, 2001; 85(2): 171 - 178. [Abstract] [Full Text]

				M. Brignole and M. Gammage A novel use of cardiac pacing to improve cardiac function in patients with heart failure and permanent atrial fibrillation Europace, January 1, 2001; 3(2): 150 - 152. [PDF]

				M. H. Hamdan, R. L. Page, C. J. Sheehan, J. D. Zagrodzky, S. L. Wasmund, K. Ramaswamy, J. A. Joglar, and M. L. Smith Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation J. Am. Coll. Cardiol., July 1, 2000; 36(1): 151 - 158. [Abstract] [Full Text] [PDF]

				B. Luderitz and W. Jung Quality of Life in Patients With Atrial Fibrillation Arch Intern Med, June 26, 2000; 160(12): 1749 - 1757. [Abstract] [Full Text] [PDF]

				M. M. Scheinman Mechanisms of atrial fibrillation: is a cure at hand? J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1687 - 1692. [Abstract] [Full Text] [PDF]

				M Gasparini, M Mantica, M Brignole, L Gianfranchi, C Menozzi, F Pizzetti, G Magenta, P Delise, A Proclemer, S Tognarin, et al. Thromboembolism after atrioventricular node ablation and pacing: long term follow up Heart, October 1, 1999; 82(4): 494 - 498. [Abstract] [Full Text] [PDF]

				H. J. Marshall, Z. I. Harris, M. J. Griffith, R. L. Holder, and M. D. Gammage Prospective Randomized Study of Ablation and Pacing Versus Medical Therapy for Paroxysmal Atrial Fibrillation : Effects of Pacing Mode and Mode-Switch Algorithm Circulation, March 30, 1999; 99(12): 1587 - 1592. [Abstract] [Full Text] [PDF]

				S. Levy Atrioventricular junctional ablation and pacing for paroxysmal atrial fibrillation: the Barcelona recommendations Europace, January 1, 1999; 1(1): 2 - 4. [PDF]

				M. Brignole, M. Gammage, L. Jordaens, R. Sutton, and on behalf of the Barcelona Discussion Group Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation Europace, January 1, 1999; 1(1): 8 - 13. [Abstract] [PDF]

				H. J. Marshall and M. J. Griffith Ablation of the atrioventricular junction: Technique, acute and long-term results in 115 consecutive patients Europace, January 1, 1999; 1(1): 26 - 29. [Abstract] [PDF]

				M. M. Scheinman Atrial Fibrillation and Congestive Heart Failure : The Intersection of Two Common Diseases Circulation, September 8, 1998; 98(10): 941 - 942. [Full Text] [PDF]

				M. Brignole, C. Menozzi, L. Gianfranchi, G. Musso, R. Mureddu, N. Bottoni, and G. Lolli Assessment of Atrioventricular Junction Ablation and VVIR Pacemaker Versus Pharmacological Treatment in Patients With Heart Failure and Chronic Atrial Fibrillation : A Randomized, Controlled Study Circulation, September 8, 1998; 98(10): 953 - 960. [Abstract] [Full Text] [PDF]

				M BRIGNOLE Ablate and pace: a pragmatic approach to paroxysmal atrial fibrillation not controlled by antiarrhythmic drugs Heart, June 1, 1998; 79(6): 531 - 533. [Full Text]

				H J Marshall, Z I Harris, M J Griffith, and M D Gammage Atrioventricular nodal ablation and implantation of mode switching dual chamber pacemakers: effective treatment for drug refractory paroxysmal atrial fibrillation Heart, June 1, 1998; 79(6): 543 - 547. [Abstract] [Full Text]

				A. D. Krahn, G. J. Klein, R. Yee, M. N. Basta, and J. K. Lee Progressive Anterior Ablation in the Coronary Sinus Region : Evidence to Support the Presence of a `Slow Pathway' Input in Normal Patients? Circulation, November 18, 1997; 96(10): 3477 - 3483. [Abstract] [Full Text]